Ashour, S. and Bayram, R. (2015) Development and Validation of Sensitive Kinetic Spectrophotometric Method for the Determination of Moxifloxacin Antibacterial Agent in Pure and Commercial Tablets. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 140, 216-222.
https://doi.org/10.1016/j.saa.2014.12.111

has been cited by the following article:

• TITLE: Substandard/Falsification Antibacterial Agents: A Systematic Review of Liquid Chromatographic and Spectrophotometric Methods for Their Detection

  AUTHORS: Pierrot Mwamba Tshilumba, Moke Muindu, Mutshitshi Kasongo, Gaelle Kalonji Mujinga, Mbedi Zabakani, Joel Kabadi Kasongo, Musumba Tshamba, Jean-Claude Nkwanga, Roland Marini Djang’eing’a, Pierre Duez, Jean-Baptiste Kalonji Ndoumba

  KEYWORDS: Counterfeiting/Falsification/Substandard Antibacterial, Liquid Chromatography/Spectrophotometry UV/Vis

  JOURNAL NAME: American Journal of Analytical Chemistry, Vol.10 No.8, August 26, 2019

  ABSTRACT: Falsified antibacterial agents continue to pose serious public health problems around the world. They are notably responsible for resistance emergence in the treatment of infectious diseases that can lead to death. The aim of this study was to summarize the literature on the methods developed and validated to detect poor quality antibacterial agents in order to assess the impact of these available methods in the fighting against Counterfeit/substandard medicines. Thus, studies published in the time from January 2000 to July 2017, were accessible via Google Scholar and Pubmed and allowed to analyze 41 papers. The majority (30) of developed and validated methods concerned LC methods, 9 regarded UV/V is spectrophotometry and two studies simultaneously developed both methods. Antibacterial agents belonging to beta-lactams group were the most concerned by the methods developed and validated (39%), followed by quinolones (18%) and macrolides (12%). Regarding active ingredients, amoxicillin (12%) was the most concerned by the development and validation methods. In spite of several available methods to detect substandard drugs, antibacterial agents for which methods were developed and validated were the most concerned by worldwide detected non-conformities. The fight against this scourge should not be only limited by their detection, but it also requires an effective involvement of different actors notably: health authorities, international organizations, pharmaceutical industries etc.